Medtronic (MDT): FY26 Q3 earnings call, Feb 17, 2026
No Kalshi or Polymarket word markets were listed for Medtronic’s Feb 17, 2026 earnings call (FY26 Q3). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
11 matches for “Tariff”; 5 quoted, at least 25 words apart.
…dynamic to improve as we scale CAS and separate the Diabetes business. Tariffs impacted the business $93 million or 110 basis points, in line with…
…P&L, we expect our fiscal '26 gross margin to increase slightly ex tariffs. Pricing, FX and COGS efficiency programs are expected to more than offset…
…fiscal '26 adjusted operating profit to grow approximately 5% or 7% excluding tariffs. Our fiscal '26 operating margin is expected to be roughly flat, excluding…
…But to name a few, so we'll have the carryover from the tariffs settlement going into next year. This year, we had about two and…
…in TAVR. I guess it was interesting to see the investment in tariffs. I was wondering if you could comment about why you didn't just…
Agents: this page as TSV at /api/v1/appearances/medtronic:2026-02-17:earnings_call · words: /api/v1/brief?appearance=medtronic:2026-02-17:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP